Public Profile

Apotex Corp.

Apotex Corp., a leading global pharmaceutical company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1974, Apotex has established itself as a key player in the generic and specialty pharmaceuticals industry, focusing on the development, manufacturing, and distribution of high-quality medications. With a diverse portfolio that includes over 300 generic products and innovative formulations, Apotex is renowned for its commitment to affordability and accessibility in healthcare. The company has achieved significant milestones, including numerous FDA approvals and a strong presence in both the retail and hospital sectors. Apotex's dedication to quality and patient care has solidified its position as a trusted name in the pharmaceutical landscape, making it a vital contributor to global health solutions.

DitchCarbon Score

How does Apotex Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Apotex Corp.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Apotex Corp.'s reported carbon emissions

Apotex Corp., headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate commitments, often aligning with industry standards to reduce their carbon footprints. As Apotex navigates its environmental responsibilities, it may consider establishing measurable targets and initiatives to enhance its climate strategy in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Apotex Corp.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Apotex Corp. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Apotex Corp. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hikma Pharmaceuticals USA Inc.

US
Updated 3 months ago
DitchCarbon Score

Phastar

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

American Regent, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Fresenius Kabi USA, LLC

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Nexus Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Accord Healthcare Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers